118.21
price down icon0.44%   -0.52
after-market アフターアワーズ: 118.21
loading
前日終値:
$118.73
開ける:
$119.5
24時間の取引高:
583.88K
Relative Volume:
0.64
時価総額:
$5.38B
収益:
$1.33B
当期純損益:
$97.31M
株価収益率:
58.18
EPS:
2.0317
ネットキャッシュフロー:
$260.44M
1週間 パフォーマンス:
-2.88%
1か月 パフォーマンス:
+9.05%
6か月 パフォーマンス:
+93.25%
1年 パフォーマンス:
+133.11%
1日の値動き範囲:
Value
$117.20
$120.50
1週間の範囲:
Value
$117.00
$122.46
52週間の値動き範囲:
Value
$48.98
$123.77

Haemonetics Corp Stock (HAE) Company Profile

Name
名前
Haemonetics Corp
Name
セクター
Healthcare (1052)
Name
電話
(781) 848-7100
Name
住所
125 SUMMER STREET, BOSTON, MA
Name
職員
3,009
Name
次回の収益日
2026-11-05
Name
最新のSEC提出書
Name
HAE's Discussions on Twitter

Compare HAE vs ABT, MDT, SYK, BSX, EW

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
HAE icon
HAE
Haemonetics Corp
118.21 5.38B 1.33B 97.31M 260.44M 2.0317
ABT icon
ABT
Abbott Laboratories
102.45 177.28B 46.59B 5.41B 7.38B 3.0938
MDT icon
MDT
Medtronic Plc
94.63 121.04B 36.36B 4.84B 5.43B 3.7261
SYK icon
SYK
Stryker Corp
304.40 116.76B 25.27B 3.34B 4.57B 8.6334
BSX icon
BSX
Boston Scientific Corp
45.58 66.06B 20.62B 3.56B 3.48B 2.3847
EW icon
EW
Edwards Lifesciences Corp
88.29 50.89B 6.30B 1.07B 1.09B 1.8406

Haemonetics Corp Stock (HAE) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-09-17 アップグレード Citigroup Neutral → Buy
2026-05-22 アップグレード BofA Securities Neutral → Buy
2026-05-12 繰り返されました Barrington Research Outperform
2025-12-15 ダウングレード Needham Buy → Hold
2025-12-11 ダウングレード Citigroup Buy → Neutral
2025-08-11 ダウングレード Raymond James Strong Buy → Outperform
2025-08-08 繰り返されました Barrington Research Outperform
2025-08-08 ダウングレード JP Morgan Overweight → Neutral
2025-07-09 アップグレード Citigroup Neutral → Buy
2025-06-26 開始されました Robert W. Baird Outperform
2025-02-07 ダウングレード BofA Securities Neutral → Underperform
2024-12-06 開始されました JP Morgan Overweight
2024-11-08 アップグレード Raymond James Outperform → Strong Buy
2024-09-13 開始されました CL King Buy
2024-09-11 開始されました BofA Securities Neutral
2024-09-10 開始されました BTIG Research Buy
2024-06-12 アップグレード Needham Hold → Buy
2022-10-13 開始されました Mizuho Buy
2022-01-27 ダウングレード Needham Buy → Hold
2021-12-15 ダウングレード Citigroup Buy → Neutral
2021-08-17 再開されました Raymond James Outperform
2021-06-17 開始されました Citigroup Buy
2021-05-14 アップグレード CJS Securities Market Perform → Market Outperform
2021-04-20 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-04-19 ダウングレード CJS Securities Market Outperform → Market Perform
2021-02-03 アップグレード Barrington Research Mkt Perform → Outperform
2021-01-21 ダウングレード Barrington Research Outperform → Mkt Perform
2020-11-05 アップグレード Barrington Research Mkt Perform → Outperform
2020-05-06 ダウングレード Barrington Research Outperform → Mkt Perform
2020-03-31 アップグレード CJS Securities Market Perform → Market Outperform
2020-01-10 開始されました Needham Buy
2019-08-07 繰り返されました Barrington Research Outperform
2019-05-14 アップグレード Raymond James Mkt Perform → Outperform
2019-05-08 繰り返されました Barrington Research Outperform
2018-08-09 繰り返されました Barrington Research Outperform
2018-02-07 繰り返されました Barrington Research Outperform
2018-01-02 アップグレード Morgan Stanley Equal-Weight → Overweight
2017-11-08 繰り返されました Barrington Research Outperform
2017-08-08 アップグレード Barrington Research Mkt Perform → Outperform
2017-07-13 アップグレード JMP Securities Mkt Perform → Mkt Outperform
2017-02-07 ダウングレード Barrington Research Outperform → Mkt Perform
2016-11-08 アップグレード Barrington Research Mkt Perform → Outperform
2016-11-07 繰り返されました The Benchmark Company Hold
2016-09-20 ダウングレード CJS Securities Market Outperform → Market Perform
2016-08-15 ダウングレード Sidoti Buy → Neutral
2016-08-02 繰り返されました Jefferies Buy
2016-08-02 繰り返されました The Benchmark Company Hold
すべてを表示

Haemonetics Corp (HAE) 最新ニュース

pulisher
Oct 16, 2026

Haemonetics Gains 149.3% in a Year: What's Driving the Rally? - Zacks Investment Research

Oct 16, 2026
pulisher
Oct 13, 2026

Why Haemonetics (HAE) is a Top Momentum Stock for the Long-Term - Zacks Investment Research

Oct 13, 2026
pulisher
Oct 09, 2026

Haemonetics: CSL Plasma Improves The Outlook, Not The Entry Point (Rating Downgrade) - Seeking Alpha

Oct 09, 2026
pulisher
Oct 09, 2026

Haemonetics Corporation (HAE) Stock Forecasts - Yahoo! Finance Canada

Oct 09, 2026
pulisher
Oct 09, 2026

Strength Seen in Haemonetics (HAE): Can Its 17.5% Jump Turn into More Strength? - Zacks Investment Research

Oct 09, 2026
pulisher
Oct 09, 2026

Strength Seen in Haemonetics (HAE): Can Its 17.5% Jump Turn into More Strength? - Yahoo Finance

Oct 09, 2026
pulisher
Oct 09, 2026

Haemonetics (HAE) Jumped, What Is Behind The Move? - Yahoo Finance

Oct 09, 2026
pulisher
Oct 09, 2026

Haemonetics (HAE) Surges Over 17% on Plasma Supply Deal with CSL - GuruFocus

Oct 09, 2026
pulisher
Oct 08, 2026

Haemonetics Corporation Stock 12‑Month Price Target Raised to $120, Implies 18% Upside - TradingView

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics advances 17% on CSL supply deal (HAE:NYSE) - Seeking Alpha

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics (HAE) Jumps As Citi Hikes Price Target To $123 - Timothy Sykes

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics (HAE) Jumps As Citi Hikes Price Target To $123 - StocksToTrade

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics (HAE) Shares Skyrocket, What You Need To Know - Yahoo Finance

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics (HAE) Surges 12.8% to $114.69 - AlphaStreet

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics Stock Climbs As Citi Hikes Price Target On CSL Upside - StocksToTrade

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics (HAE) Stock Climbs After Citi Ups Price Target - www.timothysykes.com

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics (HAE) Stock Climbs After Citi Ups Price Target - Timothy Sykes

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics Jumps to 52-Week High as CSL Plasma Plans Full U.S. Device Rollout by 2027 - finance.biggo.com

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics jumps after strong Q4 results and fiscal 2027 outlook - Quiver Quantitative

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics Stock Hits 52-Week HighHere's Why - Benzinga

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics Stock Hits 52-Week HighHere's Why - Benzinga

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics Stock Hits 52-Week HighHere's Why - TradingView

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics Says CSL Plasma to Complete Rollout of Products by End-2027 - marketscreener.com

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics Stock Pops As Citi Hikes Price Target To $123 - StocksToTrade

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics (HAE) Jumps As Citi Hikes Price Target To $123 - Timothy Sykes

Oct 08, 2026
pulisher
Oct 08, 2026

Why is Haemonetics stock surging today? - Investing.com

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics shares jump as CSL sets 2027 rollout of plasma devices - Yahoo Finance

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics (HAE) Surges 12.8% to $114.69 - AlphaStreet

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics Soars 12% on CSL Update: Plasma Giant to Roll Out NexSys Across U.S. Centers - Yahoo Finance

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics stock hits 52-week high at 114.0 USD - Investing.com

Oct 08, 2026
pulisher
Oct 08, 2026

BTIG raises Haemonetics stock price target on CSL Plasma deal - Investing.com

Oct 08, 2026
pulisher
Oct 08, 2026

Why is Haemonetics stock surging today? - Investing.com

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics stock surges 17% on CSL Plasma supply deal update - Yahoo Finance

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics Shares Gain as CSL Targets Rollout of Company's Devices by End of 2027 - marketscreener.com

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics (HAE) Secures Supply Deal with CSL Plasma for NexSys PCS Devices - GuruFocus

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics stock surges 17% on CSL Plasma supply deal update - Investing.com

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics gains after update on CSL supply deal (HAE:NYSE) - Seeking Alpha

Oct 08, 2026
pulisher
Oct 08, 2026

Haemonetics: Non‑exclusive CSL Plasma supply deal; rollout expected by end‑2027 - TradingView

Oct 08, 2026
pulisher
Oct 08, 2026

A rollout to all current U.S. CSL plasma centers is anticipated for Haemonetics (HAE), subject to change. - Stock Titan

Oct 08, 2026
pulisher
Oct 08, 2026

CSL Expands Relationship With Haemonetics Corporation - TradingView

Oct 08, 2026
pulisher
Oct 07, 2026

Haemonetics Corporation (HAE) Stock Forecasts - Yahoo Finance

Oct 07, 2026
pulisher
Oct 05, 2026

Haemonetics Q1 2027 Earnings Call Transcript - Benzinga

Oct 05, 2026
pulisher
Oct 05, 2026

BTIG reiterates Buy rating on Haemonetics with $84 target - scanx.trade

Oct 05, 2026
pulisher
Oct 05, 2026

Haemonetics stock heads into November 5 results with key benchmarks - AD HOC NEWS

Oct 05, 2026
pulisher
Oct 04, 2026

Haemonetics stock heads into November 5 results after earnings beat - AD HOC NEWS

Oct 04, 2026
pulisher
Oct 02, 2026

Haemonetics Corporation (NYSE: HAE) Share Price, HAE Stock News, HAE Share Price & Updates - kalkine.ca

Oct 02, 2026
pulisher
Oct 01, 2026

Haemonetics Corporation (HAE) Stock forecasts - Yahoo Finance Singapore

Oct 01, 2026
pulisher
Sep 30, 2026

Haemonetics Corporation (HAE) Stock Forecasts - Yahoo! Finance Canada

Sep 30, 2026
pulisher
Sep 30, 2026

Haemonetics Corporation (HAE) Stock Forecasts - Yahoo Finance

Sep 30, 2026
pulisher
Sep 30, 2026

Haemonetics sets Q2FY27 earnings release date for November 5 - scanx.trade

Sep 30, 2026

Haemonetics Corp (HAE) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$79.71
price up icon 2.01%
$126.70
price down icon 0.04%
$113.85
price up icon 3.88%
$74.75
price up icon 4.40%
$11.72
price up icon 0.77%
$291.34
price down icon 0.65%
大文字化:     |  ボリューム (24 時間):